# Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets

> **NCT03739632** · PHASE2 · COMPLETED · sponsor: **Zhejiang Huahai Pharmaceutical Co., Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Hypidone Hydrochloride tablets
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03739632
- **Lead sponsor:** Zhejiang Huahai Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2019-12-18
- **Final completion:** 2019-12-23
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739632, "Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03739632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*